Professor | Dali Li | Asia Growth Partners

Upload Avatar (500 x 500)

Name

Dali Li

Contact Information

dlli@bio.ecnu.edu.cn

Language ability

English, Chinese

Province

Shanghai

University/Lab Affiliation and Title	East China Normal University
Faculty	Life Sciences
Academic Background & Achievements	2007 - PhD in Genetics, Hunan Normal University Joint research at Texas A&M University during PhD Recipient of the 'Outstanding Youth Fund'
Work Experience	2009-2014 - East China Normal University, Life Sciences College, Promoted from Associate Professor to Researcher Current - Director at Shanghai Center for Gene Editing and Cell Therapy Current - Deputy Director at Shanghai Key Laboratory of Regulatory Biology Current - Director at East China Normal University Minhang Experimental Animal Center
Awards	2018 - First Prize in Natural Science Award from the Ministry of Education (Second Place) 2018 - Second Prize in Science and Technology Progress Award from Hainan Province (Fourth Place)

University/Lab Affiliation and Title

East China Normal University

Faculty

Life Sciences

Academic Background & Achievements

Work Experience

2009-2014 - East China Normal University, Life Sciences College, Promoted from Associate Professor to Researcher
Current - Director at Shanghai Center for Gene Editing and Cell Therapy
Current - Deputy Director at Shanghai Key Laboratory of Regulatory Biology
Current - Director at East China Normal University Minhang Experimental Animal Center

Awards

2018 - First Prize in Natural Science Award from the Ministry of Education (Second Place)
2018 - Second Prize in Science and Technology Progress Award from Hainan Province (Fourth Place)

Areas of Focus	Genetic diseases Gene therapy
Publications	Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL, Zhang J, Hu Y, Yang J, Li W, Zhang M, Wang Q, Zhang L, Wei G, Tian Y, Zhao K, Chen A, Tan B, Cui J, Li D, Li Y, Qi Y, Wang D, Wu Y, Li D, Du B, Liu M, Huang H, 2022 CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia, Fu B, Liao J, Chen S, Li W, Wang Q, Hu J, Yang F, Hsiao S, Jiang Y, Wang L, Chen F, Zhang Y, Wang X, Li D, Liu M, Wu Y, 2022

Areas of Focus

Genetic diseases
Gene therapy

Publications

Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL, Zhang J, Hu Y, Yang J, Li W, Zhang M, Wang Q, Zhang L, Wei G, Tian Y, Zhao K, Chen A, Tan B, Cui J, Li D, Li Y, Qi Y, Wang D, Wu Y, Li D, Du B, Liu M, Huang H, 2022
CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia, Fu B, Liao J, Chen S, Li W, Wang Q, Hu J, Yang F, Hsiao S, Jiang Y, Wang L, Chen F, Zhang Y, Wang X, Li D, Liu M, Wu Y, 2022

Genetic Diseases Gene Therapy Editing Clinical Research Treatment Innovation Technology

Wen Chen - Tongji University

Wenwen Jia - Tongji University

Wenzhe Li - Tongji University

View All

Personal Information